23 followers
Human insulin modulates α-synuclein aggregation via DAF-2/DAF-16 signalling pathway by antagonising DAF-2 receptor in C. elegans model of Parkinson's disease. https://t.co/bPEJzS7Hqr
Human insulin modulates α-synuclein aggregation via DAF-2/DAF-16 signalling pathway by antagonising DAF-2 receptor in C. elegans model of Parkinson's disease. https://t.co/bPEJzS7Hqr
@CSIR_CDRI researchers report that human insulin modulates α-synuclein aggregation (via DAF-2/DAF-16 signalling pathway) in C. elegans model of #Parkinsons. https://t.co/xRyyR00uMS https://t.co/OvCZYFVTac
New article: Human insulin modulates α-synuclein aggregation via DAF-2/DAF-16 signalling pathway by antagonising DAF-2 receptor in C. elegans model of Parkinson's disease. https://t.co/hEtekuEe18 #parkinsons #neurology